Shining a spotlight on cancer research developments
The Drug Discovery World Podcast
Release Date: 07/10/2024
DDW Highlights: 2 September 2024
The Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the launch of an international clinical trial investigating BioNTech’s mRNA lung cancer vaccine announced this week, our news highlights focus on clinical trials, including studies of a monoclonal antibody and small molecule GLP-1 agonist for obesity, and a muscarinic M4 selective agonist for schizophrenia. You can listen below, or find The Drug Discovery World Podcast...
info_outline
DDW Highlights: 27 August 2024
The Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. It’s been a busy week for medical regulatory agencies, with a number of key decisions made on therapies for graft-versus-host-disease, neuroendocrine carcinoma, haemophilia B, lymphoma and non-small cell lung cancer. You can listen here, or find The Drug Discovery World Podcast on , and
info_outline
How technology is impacting drug discovery
The Drug Discovery World Podcast
This is the latest episode of the free DDW narrated podcast, titled "How technology is impacting drug discovery", which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: and . In the first article, Andrew Radin, Chief Executive Officer of Aria Pharmaceuticals, on the critical use of artificial intelligence in solving some of drug discovery’s most new and complex challenges. In the second article, DDW Editor Reece Armstrong speaks to Peter Walters, Director Advanced Therapies, CRB, and Grace Linton, Director Process Architecture, CRB about...
info_outline
DDW Highlights: 19 August 2024
The Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The chosen news highlights this week all feature advances in drug development in oncology indications and reflect the breadth of therapeutic approaches to cancer treatment. You can listen below, or find The Drug Discovery World Podcast on , and
info_outline
DDW Highlights: 12 August 2024
The Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The news highlights this week all centre around significant US Food and Drug Administration (FDA) regulatory decisions, including new approvals for drugs for solid tumours, hepatitis B and glioma. You can listen here, or find The Drug Discovery World Podcast on , and
info_outline
DDW Highlights: 5 August 2024
The Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. GLP-1 receptor agonists have dominated the headlines this week, with data revealed on new potential beneficial effects of treatment with semaglutide and dual receptor agonists like pemvidutide. You can listen below, or find The Drug Discovery World Podcast on , and
info_outline
Innovation drivers and opportunities for drug discovery
The Drug Discovery World Podcast
This is the latest episode of the free DDW narrated podcast, titled "Innovation drivers and opportunities for drug discovery", which covers three articles written Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: In the first article, Svea Cheeseman from Refeyn explains why better efficiency is needed to advance the production of viral vectors for use in gene therapies. In the second article, Dr Stephen Barat, Senior Vice President and Therapeutics Division Head at HTG Molecular Diagnostics tells DDW how transcriptomics is driving drug discovery and precision...
info_outline
DDW Highlights: 29 July 2024
The Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. There have been some interesting developments in neuroscience this week. Perhaps most note-worthy, shingles vaccines Shingrix has been shown to reduce the risk of dementia by 17%, and TikoMed’s ALS drug caused a long-term slowing of ALS progression in a Phase II trial. You can listen below, or find The Drug Discovery World Podcast on , and
info_outline
Where is the global innovation and the opportunity in CGTs?
The Drug Discovery World Podcast
This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers five articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: In the first article, DDW's Megan Thomas comments on the state of the CGT industry. In the second, Ryan Leahy, a science communication expert in cell and gene therapy, at Phacilitate, says there is a lot to celebrate but also much to assess, question and challenge in this sector. In the third, DDW's Megan Thomas explores the global innovations in cell and gene...
info_outline
DDW Highlights: 22 July 2024
The Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The chosen news stories this week all feature therapies that could have significant impact on the future treatment of cancer, particularly haematological malignancies, but also solid tumours. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThis is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW.
They are called: The ‘dark matter’ behind cancer and Could this ‘Goldilocks’ drug be a non-toxic way to treat breast cancer?
In the first article, DDW Editor Reece Armstrong looks into recent research which may explain why cancers can become more aggressive.
In the second article, Armstrong covers news of a drug which could be used to treat triple-negative breast cancer with less side effects.